Early research (Phase 1)Study completedNCT01026636
What this trial is testing
A Single-Dose Pharmacokinetics and Safety Study of Ceftobiprole in Pediatric Patients =3 Months to <18 Years of Age
Who this might be right for
Staphylococcal Skin InfectionsStreptococcal Infections
Basilea Pharmaceutica 64